Quote & Headlines
5d 1m 3m 1y 5y 10y
To learn more about Seeking Alpha PRO, click here.
There are no Transcripts on HART.
HART vs. ETF Alternatives
Currently, there's no company description for HART.
Country: United States
Monday, Nov 48:45 AMHarvard Bioscience completes regenerative medicine device spin-off
Monday, Nov 48:45 AM| 6 Comments
- Harvard Bioscience (HBIO) is off 16% premarket after completing a spin-off of its regenerative medicine device subsidiary.
- Harvard Apparatus Regenerative Technology now trades on the Nasdaq under the ticker HART.
- HBIO shareholders got one share of HART for every share of HBIO they owned as of October 21.
- HBIO now calls itself a "pure-play global developer, manufacturer and marketer of a broad range of tools to advance life science research." (PR)
- CEO Jeffrey Duchemin has been appointed President and Director, replacing David Green who is now HART's President.